Prostate Cancer
Latent hypothyreosis as a clinical biomarker for therapy response under abiraterone acetate therapy - Abstract
February 6, 2014
Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer - Abstract
February 6, 2014
Vitamin D and prostate cancer survival in veterans - Abstract
February 6, 2014
Sensorimotor polyneuropathy and foot-drop as result of a prostate cancer paraneoplastic syndrome - Abstract
February 6, 2014
(11)C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy - Abstract
February 6, 2014
Potential usefulness of CTC detection in follow up of prostate cancer patients. A preliminary report obtained by using Adnagene platform - Abstract
February 6, 2014
Prostate-specific antigen screening: A critical review of current research and guidelines - Abstract
February 6, 2014
Individualized estimates of overdiagnosis in screen-detected prostate cancer - Abstract
February 6, 2014
Medical oncology consultation and minimization of overtreatment in men with low-risk prostate cancer - Abstract
February 5, 2014